Do We Plan to Remediate or Attempt to Prevent?

Do We Know What We Do not Know? A Response to Celine Bonnet

Diagnostic and therapeutic challenges for dermatologists: What shall we do when we don’t know what to do?

What shall we do when we have done everything we could for the diagnosis and treatment of a patient, but were not successful? What shall we do when there is no definite treatment for a patient? What shall we do when we have no diagnosis or treatment for a patient? Some useful suggestions are presented here to get rid of these situations.

Molecular approaches to diagnosis of invasive aspergillosis what we know and what we do not know.

Invasive aspergillosis (IA) are a major complication in immunocompromized patients where can be serious and rapidly fatal. Early diagnosis and early appropriate antifungal treatment is important in reducing mortality and morbidity. But despite many efforts to develop detection methods, the diagnosis of IA still remains challenging and current conventional methods are limited for adequate diagno...

What can we do to prevent listeriosis in 2006?

Investigations of outbreaks of listeriosis during the 1980s demonstrated that lis-teriosis is a foodborne disease. With the exception of 4 large outbreaks occurring in the United States, the United Kingdom, and France, each of which involved 1100 cases, most listeriosis outbreaks have involved few cases (usually !20 cases). Throughout Europe and the United States, the majority of cases of liste...

Do we have the tools to prevent phantom limb pain?

P ERSISTENT pain after limb amputation is common, most often taking the form of phantom limb pain or localized pain in the residual portion of the limb (stump pain). The conflicts in Afghanistan and Iraq have brought this to the forefront: in a report appearing in 2008, of the 8,058 reported military casualties in US military personnel, 5,684 (70.5%) had major limb injuries; and 423 (7.4%) of p...